Issue Date: September 14, 2009
Liquidia Raises Funds For Nanopolymer
Nanotechnology start-up Liquidia Technologies has raised $7 million in a third round of venture capital financing, led by Canaan Partners. Liquidia has developed a polymer technology to create micro- and nanoparticles for drug delivery. The company plans to use the funds to advance its first product, a vaccine, into Phase I clinical studies in late 2010. It will also invest in manufacturing clinical supplies of the drug.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society